Sveriges mest populära poddar
Bloomberg Businessweek
NyheterNäringsliv

Bloomberg Markets: Anavex CEO on Neurodegenerative Disorders

10 min•5 juni 2017

Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Dr. Christopher Missling CEO Anavex Discussing current state of research into neurodegenerative disorders, such as Alzheimer's disease and Parkinson’s, and Anavex’s approach with ANAVEX 2-73. Caroline Hyde of Bloomberg Television also participates in the conversation.

See omnystudio.com/listener for privacy information.

Fler avsnitt av Bloomberg Businessweek

Visa alla avsnitt av Bloomberg Businessweek
US Tells Iran’s Trade Partners to Cut Ties or Face Sanctions
•42 min
Inside Trump's Months-Long Effort to Get His Signature on US Currency
•12 min
Bloomberg Businessweek Weekend: August 21st, 2026
•39 min
Treasury Whiplash Leaves Traders Guessing Scott Bessent's Next Move
•36 min
Texas Is the Tip of a Melting Muni Iceberg: How a 'Boycott' Led to Higher Costs
•12 min
Broadcom Seeks More Than $60 Billion in Latest AI Debt Deal
•35 min
Rocks, Lime, Concrete & Steel: Investing in AI Data Center Building Blocks
•7 min
Fed Minutes Show Many Officials Said Rate Hikes May Be Needed
•46 min
Oliver Kharraz, Zocdoc CEO
•12 min
Global Bond Anxiety Builds on Long-Term Debt Cost Increase
•39 min

Bloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.